Shortness of breath and cough in patients in palliative care;Atemnot und Husten bei Palliativpatienten

Deutsches Arzteblatt International

Volumn 110, Issue 33-34, 2013, Pages 563-572

  Bausewein, Claudia ^a   Simon, Steffen T ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; ANTIDEPRESSANT AGENT; ANTITUSSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DEXTROMETHORPHAN; EXPECTORANT AGENT; FENTANYL; MORPHINE; OPIATE; SEROTONIN UPTAKE INHIBITOR; STEROID;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DYING; DYSPNEA; EMERGENCY CARE; EMOTIONAL STRESS; HUMAN; KINESIOTHERAPY; NEUROMUSCULAR ELECTRICAL STIMULATION; OXYGEN THERAPY; PALLIATIVE THERAPY; PHYSICAL ACTIVITY; PHYSICAL STRESS;

COMBINED MODALITY THERAPY; COMORBIDITY; COUGH; DYSPNEA; FEMALE; HUMANS; INCIDENCE; MALE; MIND-BODY THERAPIES; PALLIATIVE CARE; PHYSICAL THERAPY MODALITIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84883729386     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0563     Document Type: Article

References (39)

1. Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A: Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 2007; 34: 94-104.
2. Parshall MB, Schwartzstein RM, Adams L, et al.: An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-52.
3. Wee B, Browning J, Adams A, et al.: Management of chronic cough in patients receiving palliative care: review of evidence and recommendations by a task group of the Association for Palliative Medicine of Great Britain and Ireland. Palliat Med 2012; 26: 780-7.
4. Solano JP, Gomes B, Higginson IJ: A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31: 58-69.
5. Bausewein C, Booth S, Gysels M, Kuhnbach R, Haberland B, Higginson IJ: Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study. Palliat Med 2010; 24: 777-86.
6. Tataryn D, Chochinov HM: Predicting the trajectory of will to live in terminally ill patients. Psychosomatics 2002; 43: 370-7.
7. Homsi J, Luong D: Symptoms and survival in patients with ad - vanced disease. J Palliat Med 2007;10: 904-9.
8. Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SC: Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol 2012; 84: 130-48.
9. Escalante CP, Martin CG, Elting LS, et al.: Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer 1996; 78: 1314-9.
10. Booth S, Silvester S, Todd C: Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care 2003; 1: 337-44.
11. Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E: Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 2009; 12: 29-36.
12. Simon ST, Higginson IJ, Benalia H, et al.: Episodic and Continuous Breathlessness: A New Categorization of Breathlessness. JJ Pain Symptom Manage. J Pain Symptom Manage 2013; 45: 1019-29.
13. Kvale PA: Chronic cough due to lung tumors: ACCP evidence-based clinical practice guidelines. Chest 2006; 129 (Suppl): 47-53.
14. Myers J: Physiology and pathophysiology of cough. In: Ahmedzai SH, Muers MF, (eds): Supportive care in respiratory disease. Oxford: Oxford University Press 2005; 341-64.
15. Booth S, Moosavi SH, Higginson IJ: The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nat Clin Pract Oncol 2008; 5: 90-100.
16. Bausewein C, Booth S, Gysels M, Higginson I: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008(2): CD005623.
17. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S: Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010; 39: 831-8.
18. Taylor J: The non-pharmacological management of breathlessness. End of Life Care 2007; 1: 20-9.
19. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ: Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333-7.
20. Vivodtzev I, Pepin JL, Vottero G, et al.: Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest 2006; 129: 1540-8.
21. Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohsenin V: Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 2002; 57: 1045-9.
22. Jennings AL, Davies AN, Higgins JP, Broadley K: Opioids for the palliation of breathlessness in terminal illness. Cochrane Database of Systematic Reviews(4): CD002066.
23. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C: Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327: 523-8.
24. Simon ST, Koskeroglu P, Gaertner J, Voltz R: Fentanyl for the relief of refractory breathlessness: A systematic review. J Pain Symptom Manage. 2013 Jun 4. doi: pii: S0885-3924(13)00239-X. 10.1016/j.jpainsymman.2013.02.019. [Epub ahead of print]
25. Jensen D, Alsuhail A, Viola R, Dudgeon DJ, Webb KA, O'Donnell DE: Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage 2012; 43: 706-19.
26. Currow DC, McDonald C, Oaten S, et al.: Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 2011; 42: 388-99.
27. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C: Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010: CD007354.
28. Matsuo N, Morita T, Iwase S: Efficacy and undesirable effects of corticosteroid therapy experienced by palliative care specialists in Japan: a nationwide survey. J Palliat Med 2011; 14: 840-5.
29. Smoller JW, Pollack MH, Systrom D, Kradin RL: Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 1998; 39: 24-9.
30. Abernethy AP, McDonald CF, Frith PA, et al.: Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 2010; 376: 784-93.
31. Bolser DC, Davenport PW: Codeine and cough: an ineffective gold standard. Curr Opin Allergy Clin Immunol 2007; 7: 32-6.
32. Freestone C, Eccles R: Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol 1997; 49: 1045-9.
33. Smith J, Owen E, Earis J, Woodcock A: Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol 2006; 117: 831-5.
34. Morice AH, Menon MS, Mulrennan SA, et al.: Opiate therapy in chronic cough. Am J Respir Crit Care Med 2007; 15; 175: 312-5.
35. Homsi J, Walsh D, Nelson KA: Important drugs for cough in ad - vanced cancer. Support Care Cancer 2001; 9: 565-74.
36. Matthys H, Bleicher B, Bleicher U: Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough. J Int Med Res 1983; 11: 92-100.
37. Howard P, Cayton RM, Brennan SR, Anderson PB: Lignocaine aerosol and persistent cough. Br J Dis Chest 1977; 71: 19-24.
38. Sanders RV, Kirkpatrick MB: Prolonged suppression of cough after inhalation of lidocaine in a patient with sarcoid. JAMA 1984; 252: 2456-7.
39. Schildmann EK, Remi C, Bausewein C: Levodropropizine in the management of cough associated with cancer or nonmalignant chronic disease-a systematic review. J Pain Palliat Care Pharmacother 2011; 25: 209-18.